MedPath

ABRAXIS BIOSCIENCE, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:3
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

2

FDA:1
SFDA:1

Drug Approvals

ABRAXANE

Approval Date
Oct 31, 2022
FDA

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.